vs

Side-by-side financial comparison of Bloom Energy Corp (BE) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Bloom Energy Corp is the larger business by last-quarter revenue ($751.1M vs $493.8M, roughly 1.5× Pediatrix Medical Group, Inc.). Bloom Energy Corp runs the higher net margin — 9.4% vs 6.8%, a 2.6% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -3.4%). Over the past eight quarters, Bloom Energy Corp's revenue compounded faster (51.7% CAGR vs -0.1%).

KR Sridhar is an Indian American engineer, inventor, professor, and entrepreneur. He is the founder, chairman, and chief executive officer (CEO) of Bloom Energy. Prior, Sridhar was a professor of Aerospace and Mechanical Engineering and the Director of the Space Technologies Laboratory (STL) at the University of Arizona. He worked with and advised NASA, and is a member of the National Academy of Engineering.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

BE vs MD — Head-to-Head

Bigger by revenue
BE
BE
1.5× larger
BE
$751.1M
$493.8M
MD
Growing faster (revenue YoY)
MD
MD
+1.7% gap
MD
-1.7%
-3.4%
BE
Higher net margin
BE
BE
2.6% more per $
BE
9.4%
6.8%
MD
Faster 2-yr revenue CAGR
BE
BE
Annualised
BE
51.7%
-0.1%
MD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BE
BE
MD
MD
Revenue
$751.1M
$493.8M
Net Profit
$70.7M
$33.7M
Gross Margin
30.0%
Operating Margin
17.3%
9.9%
Net Margin
9.4%
6.8%
Revenue YoY
-3.4%
-1.7%
Net Profit YoY
396.7%
10.5%
EPS (diluted)
$0.44
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BE
BE
MD
MD
Q1 26
$751.1M
Q4 25
$772.8M
$493.8M
Q3 25
$513.3M
$492.9M
Q2 25
$396.3M
$468.8M
Q1 25
$319.3M
$458.4M
Q4 24
$567.0M
$502.4M
Q3 24
$321.8M
$511.2M
Q2 24
$326.5M
$504.3M
Net Profit
BE
BE
MD
MD
Q1 26
$70.7M
Q4 25
$1.4M
$33.7M
Q3 25
$-23.0M
$71.7M
Q2 25
$-42.2M
$39.3M
Q1 25
$-23.4M
$20.7M
Q4 24
$105.2M
$30.5M
Q3 24
$-14.6M
$19.4M
Q2 24
$-61.2M
$-153.0M
Gross Margin
BE
BE
MD
MD
Q1 26
30.0%
Q4 25
31.0%
Q3 25
29.5%
Q2 25
27.0%
Q1 25
27.8%
Q4 24
38.7%
Q3 24
24.5%
Q2 24
21.0%
Operating Margin
BE
BE
MD
MD
Q1 26
17.3%
Q4 25
11.3%
9.9%
Q3 25
1.5%
13.8%
Q2 25
-0.9%
12.8%
Q1 25
-6.0%
7.0%
Q4 24
18.5%
7.8%
Q3 24
-3.0%
6.6%
Q2 24
-7.1%
-31.3%
Net Margin
BE
BE
MD
MD
Q1 26
9.4%
Q4 25
0.2%
6.8%
Q3 25
-4.5%
14.5%
Q2 25
-10.6%
8.4%
Q1 25
-7.3%
4.5%
Q4 24
18.5%
6.1%
Q3 24
-4.5%
3.8%
Q2 24
-18.7%
-30.3%
EPS (diluted)
BE
BE
MD
MD
Q1 26
$0.44
Q4 25
$99.91
$0.40
Q3 25
$-100.00
$0.84
Q2 25
$-0.18
$0.46
Q1 25
$-0.10
$0.24
Q4 24
$0.45
$0.37
Q3 24
$-0.06
$0.23
Q2 24
$-0.27
$-1.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BE
BE
MD
MD
Cash + ST InvestmentsLiquidity on hand
$375.2M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$948.0K
$865.9M
Total Assets
$4.7B
$2.2B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BE
BE
MD
MD
Q1 26
Q4 25
$2.5B
$375.2M
Q3 25
$595.1M
$340.1M
Q2 25
$574.8M
$224.7M
Q1 25
$794.8M
$99.0M
Q4 24
$802.9M
$229.9M
Q3 24
$495.7M
$103.8M
Q2 24
$581.7M
$19.4M
Total Debt
BE
BE
MD
MD
Q1 26
Q4 25
$2.6B
$570.5M
Q3 25
$1.1B
$577.2M
Q2 25
$1.1B
$583.9M
Q1 25
$1.1B
$590.5M
Q4 24
$1.1B
$597.1M
Q3 24
$1.1B
Q2 24
$1.1B
Stockholders' Equity
BE
BE
MD
MD
Q1 26
$948.0K
Q4 25
$768.6M
$865.9M
Q3 25
$653.1M
$890.7M
Q2 25
$594.6M
$833.8M
Q1 25
$578.3M
$789.2M
Q4 24
$562.5M
$764.9M
Q3 24
$430.9M
$732.5M
Q2 24
$423.3M
$706.5M
Total Assets
BE
BE
MD
MD
Q1 26
$4.7B
Q4 25
$4.4B
$2.2B
Q3 25
$2.6B
$2.2B
Q2 25
$2.5B
$2.1B
Q1 25
$2.6B
$2.0B
Q4 24
$2.7B
$2.2B
Q3 24
$2.6B
$2.1B
Q2 24
$2.5B
$2.0B
Debt / Equity
BE
BE
MD
MD
Q1 26
Q4 25
3.41×
0.66×
Q3 25
1.73×
0.65×
Q2 25
1.91×
0.70×
Q1 25
1.96×
0.75×
Q4 24
2.01×
0.78×
Q3 24
2.62×
Q2 24
2.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BE
BE
MD
MD
Operating Cash FlowLast quarter
$114.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BE
BE
MD
MD
Q1 26
Q4 25
$418.1M
$114.1M
Q3 25
$19.7M
$137.3M
Q2 25
$-213.1M
$137.2M
Q1 25
$-110.7M
$-117.5M
Q4 24
$484.2M
$133.0M
Q3 24
$-69.5M
$91.8M
Q2 24
$-175.5M
$107.0M
Free Cash Flow
BE
BE
MD
MD
Q1 26
Q4 25
$395.1M
Q3 25
$7.4M
Q2 25
$-220.4M
Q1 25
$-124.9M
Q4 24
$473.1M
Q3 24
$-83.8M
Q2 24
$-187.5M
FCF Margin
BE
BE
MD
MD
Q1 26
Q4 25
51.1%
Q3 25
1.4%
Q2 25
-55.6%
Q1 25
-39.1%
Q4 24
83.4%
Q3 24
-26.0%
Q2 24
-57.4%
Capex Intensity
BE
BE
MD
MD
Q1 26
Q4 25
3.0%
Q3 25
2.4%
Q2 25
1.8%
Q1 25
4.5%
Q4 24
2.0%
Q3 24
4.4%
Q2 24
3.7%
Cash Conversion
BE
BE
MD
MD
Q1 26
Q4 25
293.18×
3.39×
Q3 25
1.91×
Q2 25
3.49×
Q1 25
-5.66×
Q4 24
4.60×
4.36×
Q3 24
4.72×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BE
BE

Product$653.3M87%
Service$61.9M8%
Installation$25.9M3%
Electricity$9.9M1%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons